Chemical Formula: C22H36O7
Chemical Formula C22H36O7
Found 55 metabolite its formula value is C22H36O7
Rhodotoxine
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Asebotoxin
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
3alpha-hydroxy-beta-eudesmol-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-beta-eudesmol-
5,6-dehydro-alpha-eudesmol-(alpha-xylopyranoside-2-O-acetate)|5,6-dehydro-alpha-eudesmol-
9-hydroxy-3-O-(2-O-acetyl-beta-D-xylopyranosyl)-nerolidol
15-hydroxy-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|15-hydroxy-gamma-eudesmol-
C22H36O7_Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R,16alpha)
grayanotoxin I
A tetracyclic diterpenoid that is grayanotoxane in which the pro-R hydrogen at position 14 is substituted by an acetoxy group and in which the 3beta-, 5-, 6beta-, 10-, and 16- positions are substituted by hydroxy groups. D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
[(1S,3R,4R,6S,8S,9R,10R,13R,14R,16S)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyl-16-tetracyclo[11.2.1.01,10.04,8]hexadecanyl] acetate
(2r,3r,4s,5r)-4-(acetyloxy)-2-[(3,7-dimethylocta-2,6-dien-1-yl)oxy]-5-hydroxyoxan-3-yl (2r)-2-methylbutanoate
4,6,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
4,5-dihydroxy-2-{[2-(7-hydroxy-4a-methyl-8-methylidene-octahydronaphthalen-2-yl)propan-2-yl]oxy}oxan-3-yl acetate
(2r,3s,4r,5s)-4,5-dihydroxy-2-{[(3s,6e,9r)-9-hydroxy-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxan-3-yl acetate
(4r,5r,6r,8r,9s)-9-(acetyloxy)-4,6,8-trimethyl-3,7-dioxoundecan-5-yl (2s)-2-methyl-3-oxopentanoate
(1s,4ar,5r,8ar)-5-{2-[(2r,3r,4s,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
(1s,4as,5r,8as)-5-{2-[(2r,3s,4r,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
(1s,2r,4as,8s,8ar)-5-(3,5-dihydroxy-3-methylpentyl)-8-hydroxy-1-(hydroxymethyl)-1,4a,6-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-2-yl acetate
(1s,4as,5r,8as)-5-{2-[(2s,3r,4s,5s)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
4,5-dihydroxy-2-({2-[8-(hydroxymethyl)-4a-methyl-3,4,5,6,7,8-hexahydro-2h-naphthalen-2-yl]propan-2-yl}oxy)oxan-3-yl acetate
(1s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-4,6,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
(2s,3r,4s,5r)-2-({2-[(2r,4as,7r,8ar)-7-hydroxy-4a-methyl-8-methylidene-octahydronaphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
(5e)-4,7,8-trihydroxy-10-oxo-2-pentyl-2,3,4,7,8,9-hexahydrooxecin-3-yl (2e)-2,4-dimethylhex-2-enoate
(1s,3r,4r,6s,8r,9r,10r,13r,14r,16s)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate
5-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
(1r,3s,4s,6r,8s,9r,10s,13s,14s,16r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate
[(1s,2r,4as,8s,8ar)-5-(3,5-dihydroxy-3-methylpentyl)-2,8-dihydroxy-1,4a,6-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]methyl acetate
(1s,3r,4r,6s,8s,9r,10r,13r,14r,16s)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate
3a,11a-dihydroxy-1,3-dimethoxy-3b,6,9a-trimethyl-decahydro-1h-phenanthro[1,2-c]furan-6-carboxylic acid
(4r,5r,6s,8r,9s)-9-(acetyloxy)-4,6,8-trimethyl-3,7-dioxoundecan-5-yl (2r)-2-methyl-3-oxopentanoate
(1r,3r,4r,6s,8r,9s,10r,13s,14r,16r)-4,6,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
(2s,3r,4s,5r)-2-({2-[(2r,4ar,8s)-8-(hydroxymethyl)-4a-methyl-3,4,5,6,7,8-hexahydro-2h-naphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
4,5-dihydroxy-2-[(9-hydroxy-3,7,11-trimethyldodeca-1,6,10-trien-3-yl)oxy]oxan-3-yl acetate
(2r,3r,4s,5r)-4-(acetyloxy)-2-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-5-hydroxyoxan-3-yl (2r)-2-methylbutanoate
(1r,3s,3ar,3br,5as,6s,9ar,9br,11ar)-3a,11a-dihydroxy-1,3-dimethoxy-3b,6,9a-trimethyl-decahydro-1h-phenanthro[1,2-c]furan-6-carboxylic acid
(2s,3r,4s,5r)-2-({2-[(2r,4ar)-8-(hydroxymethyl)-4a-methyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
(1s,2r,3s,4r)-2-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-(hydroxymethyl)cyclohex-5-ene-1,2,3,4-tetrol
4,5-dihydroxy-2-({2-[8-(hydroxymethyl)-4a-methyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)oxan-3-yl acetate
TG(12:1CHO_3:0_4:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(19:1CHO)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(15:1_4:0CHO)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(14:1_5:0CHO)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(13:1_2:0_4:0CHO)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(7:0_12:1CHO)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(15:1CHO_2:0_2:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(12:1_2:0_5:0CHO)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved